Trial Shows Canakinumab Prevents Cancer and Heart Attacks by Reducing Chronic Inflammation
Summary: Physicians implicate chronic inflammation as a cause of cancer and heart disease. In a recent trial, patients given the inflammation-lowering drug Canakinumab enjoyed a nearly a 25% decrease in heart attacks and almost a 50% decrease in cancer. [This article first appeared on LongevityFacts under the title ‘ Can We Prevent Cancer and Heart Attacks by Reducing Chronic Inflammation?’ and… Continue reading "Trial Shows Canakinumab Prevents Cancer and Heart Attacks by Reducing Chronic Inflammation"